Skip to main content
OpenTrials

Clinical trial condition

Melanoma Stage IV

Explore clinical trials studying Melanoma Stage IV. Study availability and eligibility vary by location and protocol.

43 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Melanoma Stage IV trial results

Active, not recruiting

Neoadjuvant PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor Cobolimab (TSR-022) and PD-1 Inhibitor Dostarlimab (TSR-042) in Melanoma

NCT04139902

Conditions
Melanoma, Melanoma Stage III, Melanoma Stage IV, +11 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details
Active, not recruiting

Intrathecal Double Checkpoint Inhibition

NCT05598853

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
Locations
  • University Hospital Zurich Zurich, Canton of Zurich, Switzerland
  • University Hospital Basel Basel, Switzerland
  • University Hospital Geneva Geneva, Switzerland
View Trial Details
Active, not recruiting

A Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Adults With Unresectable or Metastatic Melanoma

NCT05309421

Conditions
Melanoma, Melanoma Stage IV, Neoplasms, +11 more
Locations
  • Melanoma Institute Australia Wollstonecraft, New South Wales, Australia
  • One Clinical Research Nedlands, Western Australia, Australia
  • Divisione di Oncologia Medica del Melanoma Milan, Italy
  • Instituto Nazionale Tumori IRCCS Fondazione Naples, Italy
View Trial Details
Active, not recruiting

A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma

NCT05732805

Conditions
Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Melanoma (Skin), +16 more
Locations
  • Healthcare Institution "Bobruisk Interdistrict Oncological Dispensary" Babruysk, Belarus
  • Healthcare Institution "Brest Regional Oncological Dispensary" Brest, Belarus
  • Health care institution "Grodno University Clinic" Grodno, Belarus
  • Health Institution "Gomel Regional Clinical Oncology Center" Homyel, Belarus
View all 63 locations
View Trial Details
Completed

A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment

NCT04526899

Conditions
Melanoma, Melanoma Stage III, Melanoma Stage IV, +12 more
Locations
  • University Of Arizona College Of Medicine Tucson, Arizona, United States
  • University of California, San Francisco: Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Sylvester Comprehensive Cancer Center/ UMHC Miami, Florida, United States
  • Oncology Hematology West P.C. dba Nebraska Cancer Specialists Omaha, Nebraska, United States
View all 49 locations
View Trial Details

Related conditions